医药网5月27日讯 2.INC280片：本品也是一款c-MET抑制剂，通用名capmatinib，目前在最高研发状态为2期临床。在国内申报胶囊剂和片剂，胶囊剂已在国内进行2期临床，包括非小细胞癌...
net of medicine of the May 27 news 2.INC280 piece: This product is also a c-met inhibitor, common name capmatinib, currently at the highest state of research and development for phase 2 clinical. In the domestic reporting capsules and tablets, capsules have been carried out in the domestic 2 clinical, including non-small cell carcinoma...
